Hung-yuan Yu
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Comprehensive review of current management and precision medicine in pancreatic cancer.
Journal: Journal of the Chinese Medical Association : JCMA
Published: April 17, 2026
Adjuvant chemoradiotherapy for stage III gastric cancer: A differential role in R0 and non-R0 resection.
Journal: Journal of the Chinese Medical Association : JCMA
Published: December 30, 2025
NALIRIFOX versus liposomal irinotecan plus fluorouracil/leucovorin as the second-line chemotherapy in gemcitabine refractory pancreatic adenocarcinoma: a real-world study.
Journal: Therapeutic advances in medical oncology
Published: October 04, 2025
Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: June 18, 2025
Immunoprofile of adenosquamous carcinoma in gastric cancer.
Journal: Journal of the Chinese Medical Association : JCMA
Published: March 29, 2023
Elevated PD-L1 Expression and Microsatellite Instability in Elderly Patients With Gastric Cancer.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: July 25, 2022
Microsatellite Instability, Epstein-Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer.
Journal: Cancers
Published: November 22, 2021
Nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy: A real-world experience.
Journal: Journal of the Chinese Medical Association : JCMA
Published: November 11, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026